Normal rats and those pretreated with reserpine or cr were given L-DOPA alone or with extracerebral decarboxylase inhibitor (Ro 4-4602). l~otility was measured at two different time intervals and the brain levels of noradrenaline (NA) and dopamine (DA) were subsequently determined. No simple correl
l-Dopa feeding suppression: Effect on catecholamine neurons of the perifornical lateral hypothalamus
โ Scribed by S. F. Leibowitz; C. Rossakis
- Publisher
- Springer
- Year
- 1979
- Tongue
- English
- Weight
- 866 KB
- Volume
- 61
- Category
- Article
- ISSN
- 0033-3158
No coin nor oath required. For personal study only.
โฆ Synopsis
Injection of L-Dopa (0.8--200 nmoles) into the perifornical hypothalamus produced a dosedependent suppression of feeding in hungry rats. This effect was positively correlated in magnitude with the same effect produced by the catecholamine agonists dopamine and epinephrine, and by the catecholaminereleasing drug amphetamine. L-Dopa's action was partially antagonized by separate injections of the dopaminergic blocker haloperidol (58 ~o blockade) and the/3-adrenergic blocker propranolol (38 % blockade). Combined injections of these two antagonists produced a 90% blockade of L-Dopa's effect. Perifornical administration of the dopa decarboxylase inhibitors Ro 4-4602 and MK-486 was also shown to reverse L-Dopa's feeding suppression, at doses that enhanced the effect of injected dopamine and epinephrine. On the basis of these findings, L-Dopa appears to suppress food consumption in part through increased catecholamine synthesis, specifically within dopaminergic and adrenergic neurons of the perifornical hypothalamic region.
๐ SIMILAR VOLUMES
## Abstract The putative role of the dopaminergic system in sleep bruxism (SB) was studied in a doubleโblind clinical trial by using low doses of shortโterm Lโdopa in combination with benserazide. We recorded 10 patients with SB in our sleep laboratory for 3 consecutive nights. The first night was
## Abstract Ever since the introduction of levoโ3, 4โdihydroxyphenylalanine (Lโdopa) for the treatment of Parkinson's disease, there has been concern that it might accelerate the degeneration of dopamine neurones. Using rats with a unilateral 6โhydroxydopamine (6โOHDA) lesion of the medial forebrai
The dopa decarboxylase gene (Ddc) is located in a very dense cluster of genes many of whose functions appear to be related to the physiological role of dopa decarboxylase (DDC) in catecholamine metabolism. In Drosophila melanogaster catecholamine metabolism is involved in the production of neurotran